Who are Gentian violet 1% solution's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/gentian-violet-1-solution.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Gentian violet 1% solution — Competitive Intelligence Brief

Gentian violet 1% solution (Gentian violet 1% solution) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimicrobial dye. Area: Infectious Disease / Dermatology.

phase 3 Antimicrobial dye Infectious Disease / Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Gentian violet 1% solution (Gentian violet 1% solution) — Kamuzu University of Health Sciences. Gentian violet is a triphenylmethane dye that disrupts microbial cell membranes and inhibits bacterial and fungal growth through intercalation into nucleic acids and oxidative stress generation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Gentian violet 1% solution TARGET	Gentian violet 1% solution	Kamuzu University of Health Sciences	phase 3	Antimicrobial dye

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimicrobial dye class)

Kamuzu University of Health Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Gentian violet 1% solution — Competitive Intelligence Brief. https://druglandscape.com/ci/gentian-violet-1-solution. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab